RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status

Share Article

R-Biopharm is proud to announce the RIDASCREEN® Gliadin Competitive ELISA, for the detection and quantification of partially hydrolyzed gluten in foods, has been accepted by AOAC International as Official First Action method.

R-Biopharm is proud to announce the RIDASCREEN® Gliadin Competitive ELISA, for the detection and quantification of partially hydrolyzed gluten in foods, has been accepted by AOAC International as Official First Action method. The AOAC Official Methods Board adopted the method “Partially Hydrolyzed Gluten in Fermented Cereal-Based Products by R5 Competitive ELISA,” based on a specific monoclonal antibody to potentially celiac toxic peptide fragments. AOAC approved the Study as Official First Action and assigned it Official MethodsSM number2015.05.

The RIDASCREEN® Gliadin Competitive uses the Codex Alimentarius recommended “R5” gliadin antibody, which is generally accepted as the standard method for the detection of gluten in foods. It is currently the only Elisa available to detect partially hydrolysed samples.

“Receiving the Official Fist Action status by AOAC is a recognition of R-Biopharm’s ongoing efforts to produce the highest quality, reliable methods to ensure the safety of food and food products to protect consumers health,” said Kurt Johnson, President and General Manager, R-Biopharm Inc. “In particular with respect to those with celiac disease, we are pleased to enable gluten free food producers to manufacture according to the highest quality assurance methods.”

The use of wheat flour and gluten in foodstuffs is extremely common because of their heat stability and useful effects on texture, moisture retention and flavour. Gluten consists of two groups of proteins (prolamines and glutelins) which are present in wheat, barley, and rye. Prolamins such as gliadin have been identified as major cause for gluten intolerance (celiac disease). Celiac patients must avoid gluten in their diet.

“The RIDASCREEN® Gliadin Competitive ELISA is the most widely used method worldwide for the detection of protein frgments of gluten in foods,” said Sean Tinkey, Executive VP Sales and Marketing. “Together with the RIDA® QUICK Gliadin lateral flow test and the RIDASCREEN® Gliadin assay we can offer a complete product range for gluten management in food production.”

R-Biopharm is dedicated to develop and produce analytical methods to ensure human and animal health. The company’s food & feed diagnostics division produces test kits for quality assurance of food and feed. Products include methods for the detection of mycotoxins, allergens, antibiotics, hormones, micro-organisms etc. The R-Biopharm products are sold worldwide through a network of subsidiaries and distributors.

http://www.r-biopharm.com

Contact: Sean Tinkey; VP Sales and Marketing 269-789-3033

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Tinkey
R-Biopharm Inc
+1 (269) 789-3033
Email >

Kurt Johnson
Visit website